These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34689260)

  • 1. COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study.
    Teuschl Y; Bancher C; Brainin M; Dachenhausen A; Matz K; Pinter MM
    J Neural Transm (Vienna); 2022 Jan; 129(1):49-53. PubMed ID: 34689260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
    Santamato A; Facciorusso S; Spina S; Cinone N; Avvantaggiato C; Santoro L; Ciritella C; Smania N; Picelli A; Gasperini G; Molteni F; Baricich A; Fiore P
    Eur J Phys Rehabil Med; 2021 Jun; 57(3):424-433. PubMed ID: 33263248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
    Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
    Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort.
    Dressler D; Adib Saberi F
    J Neural Transm (Vienna); 2020 Sep; 127(9):1271-1274. PubMed ID: 32734554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany.
    Samadzadeh S; Brauns R; Rosenthal D; Hefter H
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33573065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term adherence and response to botulinum toxin in different indications.
    Lee JI; Jansen A; Samadzadeh S; Kahlen U; Moll M; Ringelstein M; Soncin G; Bigalke H; Aktas O; Moldovan AS; Waskoenig J; Jander S; Gliem M; Schnitzler A; Hartung HP; Hefter H; Albrecht P
    Ann Clin Transl Neurol; 2021 Jan; 8(1):15-28. PubMed ID: 33259153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L; Declemy A; Laffont I; Perennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak.
    Yılmaz Yalçınkaya E; Karadağ Saygı E; Özyemişci Taşkıran Ö; Çapan N; Kutlay Ş; Sonel Tur B; El Ö; Ünlü Akyüz E; Tekin S; Ofluoğlu D; Zİnnuroğlu M; Akpınar P; Özekli Mısırlıoğlu T; Hüner B; Nur H; Çağlar S; Sezgin M; Tıkız C; Öneş K; İçağasıoğlu A; Aydın R
    Turk J Med Sci; 2021 Apr; 51(2):385-392. PubMed ID: 33350298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
    Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
    JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
    Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
    Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity - Insights from recent studies.
    Wissel J
    Toxicon; 2018 Jun; 147():100-106. PubMed ID: 29407165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injection to improve functional independence and to alleviate parenting stress in a child with advanced pantothenate kinase-associated neurodegeneration: A case report and literature review.
    Lin CI; Chen KL; Kuan TS; Lin SH; Lin WP; Lin YC
    Medicine (Baltimore); 2018 May; 97(20):e10709. PubMed ID: 29768338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world analysis of botulinum toxin (BoNT) injections in post-stroke spasticity: Higher doses of BoNT and longer intervals in the early-start group.
    Woo J; Mas MF; Zhang J; Wong B; Stampas A; Francisco GE; Li S
    J Neurol Sci; 2021 Jun; 425():117449. PubMed ID: 33878656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P; Riberto M; Frances JA; Chueire R; Amorim ACFG; Xerez D; Chung TM; Mercuri LHC; Longo AL; Lianza S; Maisonobe P; Ruiz-Schutz VC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33291807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.